| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
13,213 |
5,794 |
$4.44M |
| 80053 |
Comprehensive metabolic panel |
5,945 |
4,745 |
$333K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,196 |
5,186 |
$193K |
| 36415 |
Collection of venous blood by venipuncture |
2,525 |
2,148 |
$164K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,082 |
898 |
$114K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,875 |
1,647 |
$69K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,717 |
1,359 |
$66K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,558 |
2,965 |
$40K |
| 87400 |
|
812 |
680 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
943 |
840 |
$34K |
| 71046 |
Radiologic examination, chest; 2 views |
1,178 |
972 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
454 |
385 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,817 |
1,564 |
$31K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
246 |
209 |
$28K |
| 81002 |
|
1,650 |
1,438 |
$26K |
| 81000 |
|
1,766 |
1,432 |
$21K |
| 87070 |
|
299 |
258 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,871 |
2,304 |
$18K |
| 85027 |
|
8,061 |
6,343 |
$18K |
| 87280 |
|
137 |
120 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
953 |
778 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
422 |
327 |
$13K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,287 |
1,073 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
311 |
275 |
$8K |
| 84703 |
|
368 |
323 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
135 |
110 |
$5K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
141 |
52 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
967 |
326 |
$5K |
| 81025 |
|
1,018 |
893 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,181 |
1,711 |
$4K |
| 84484 |
|
1,467 |
1,020 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
248 |
187 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
133 |
125 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
26 |
25 |
$2K |
| 86592 |
|
28 |
25 |
$2K |
| 84702 |
|
17 |
12 |
$2K |
| 83690 |
|
1,248 |
1,052 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,294 |
1,029 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
322 |
274 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,883 |
1,408 |
$1K |
| 84439 |
|
290 |
268 |
$1K |
| 85379 |
|
13 |
12 |
$713.68 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,661 |
1,360 |
$712.80 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
27 |
25 |
$700.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
121 |
$643.42 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,542 |
1,378 |
$620.35 |
| 86850 |
|
329 |
289 |
$578.80 |
| 86703 |
|
40 |
37 |
$425.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
248 |
230 |
$355.07 |
| 80061 |
Lipid panel |
205 |
183 |
$280.16 |
| 87081 |
|
12 |
12 |
$137.56 |
| 86900 |
|
294 |
258 |
$103.96 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,306 |
996 |
$74.48 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
347 |
213 |
$18.00 |
| 87186 |
|
309 |
257 |
$16.38 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
73 |
51 |
$7.57 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,321 |
1,093 |
$2.21 |
| 84100 |
|
26 |
12 |
$0.00 |
| 85610 |
|
17 |
12 |
$0.00 |
| 97161 |
|
28 |
24 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
21 |
17 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
133 |
125 |
$0.00 |
| 85651 |
|
13 |
12 |
$0.00 |
| 83735 |
|
306 |
235 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
113 |
90 |
$0.00 |
| 83605 |
|
178 |
135 |
$0.00 |
| 86901 |
|
308 |
270 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
52 |
40 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
67 |
29 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
144 |
124 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
46 |
41 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
185 |
128 |
$0.00 |
| 86803 |
|
41 |
38 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
42 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$0.00 |
| 83880 |
|
16 |
15 |
$0.00 |
| A9270 |
Non-covered item or service |
33 |
14 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
12 |
12 |
$0.00 |
| 86762 |
|
14 |
13 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
13 |
$0.00 |
| 87340 |
|
28 |
25 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
18 |
12 |
$0.00 |